Evidence Hub

Familial migraine across three generations: A case series on genetic predisposition, vascular comorbidities, treatment challenges

Karra Geetha, Madhavaneni Shishla, Atchula Sripriya, Kandi Sandhya Devi, T. R. Rao

World Journal of Biology Pharmacy and Health Sciences, 2025

Abstract

Background: Migraine is a highly prevalent neurological disease and has a significant genetic basis and shows co-occurrence in families across multiple generations. Familial migraine can differ in terms of onset, severity, triggers, and response to treatments, which can complicate management. In this case series, we share the clinical presentations, comorbidities, and treatment responses in three generations of female patients with migraine.

Methods: In this study, we identified a 67-year-old grandmother, a 48-year-old mother , and a 24-year-old young adult female with a history of migraine. Clinical data such as onset, duration, severity, associated symptoms, comorbidities and response to treatment were collected either through interviews with patients or from medical records. Drug treatments and responses were analyzed to recognize treatment response patterns across generations.

How strong is the evidence?

Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free